Using Adapted Argentine Tango to Help Breast Cancer Survivors with Neuropathy

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effects of a noninvasive, social sensorimotor intervention, specifically Adapted Argentine Tango, on breast cancer survivors suffering from chemotherapy-induced neuropathy. The study aims to restore motor control, alleviate symptoms, and enhance patient participation in treatment through partnered dance. It builds on previous pilot work and will involve a diverse cohort of participants to assess the intervention's effectiveness in improving sensory relief and functional restoration.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Breast Cancer (BC) diagnosis of Stage I-IV including metastatic disease
* completed taxane-based chemotherapy for BC at least 3 months ago (no limit on how long ago)
* symptomatic for chemotherapy-induced neuropathy (self-report)
* postural control score that indicates potential fall-risk
* able to understand and comply with directions associated with testing and study treatments

Exclusion Criteria:

* pre-existing vestibular dysfunction
* poorly controlled diabetes (hgA1C\>=8)
* non-ambulatory (assistive and prosthetic devices allowed)
* hearing impairment resulting in less than 10% hearing bilaterally
* contraindication to participate in the experimental physical activity per the treating oncologist due to additional condition (e.g., herniated disc, unstable bone metastases)
* currently in activity-based therapy (e.g., physical therapy, occupational therapy). May enroll if still meet eligibility criteria once activity-based therapy is complete.

Where it's running

• Yale University
  New Haven, Connecticut, United States Recruiting
• The Ohio State University
  Columbus, Ohio, United States Recruiting

Study contacts

• Principal investigator: Lise B Worthen-Chaudhari, PhD, MFA, CMES — Ohio State University
• Study coordinator: Lise Worthen-Chaudhari, PhD, MFA, CMES
• Email: lise.worthen-chaudhari@osumc.edu
• Phone: (1) + 614-293-6281

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• CSF sample collection from people with metastatic breast cancer to see brain metastasis risk

  This study tests whether spinal fluid and other samples can help predict brain metastases in adults with metastatic HER2-positive or triple-negative breast cancer who have not yet shown brain involvement.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07619534

• Precision MRI screening for dense breasts using Prognosia Breast risk score

  This study tests whether using the Prognosia Breast risk score with an MRI for women with very dense breasts and normal mammograms can reduce interval breast cancers.

  Recruiting Washington University School of Medicine · St Louis, Missouri · NCT07277738

• Psilocybin-assisted psychotherapy for anxiety after a cancer diagnosis

  This study will test whether psilocybin-assisted psychotherapy using NPX-5 (25 mg or 10 mg versus a low 1 mg dose) helps adults who have anxiety from adjusting to a cancer diagnosis.

  Recruiting at 5 sites Phase 2 Psyence Australia Pty Ltd · Abbotsford, Victoria and 4 other locations · NCT07072728

• ENLIGHT algorithm to find treatment options for advanced metastatic breast cancer

  This test uses the ENLIGHT algorithm to try to find approved drugs that might work better for adults with triple-negative or endocrine therapy–resistant metastatic breast cancer.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT07067138

• ChatGPT and surgeon teamwork to improve breast reconstruction consultations

  This project will test whether ChatGPT-generated patient education materials help people preparing for breast reconstruction understand their options and feel more satisfied with their surgeon consultations.

  Recruiting Washington University School of Medicine · St Louis, Missouri · NCT06981208

• Re‑irradiating the breast after a second lumpectomy

  This trial will test whether targeted re‑irradiation (IMRT) after a second lumpectomy is safe for people with ER+ / HER2‑ breast cancer who previously received breast radiation.

  Recruiting at 2 sites Baptist Health South Florida · Boca Raton, Florida and 1 other locations · NCT06867484

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.